Clinical trial
An Observational Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies
NCT01715779 is registered in ClinicalTrials.gov with Novartis as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Follow-up Study of Patients Who Experienced Thromboembolic Events in the ENABLE Studies
- Lead sponsor
- Novartis
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2012
- Completion date
- June 30, 2015
- Enrollment
- 22 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.